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(57) ABSTRACT 
A method of inducing latency in Mycobacterium permits 
preparation of an in vitro model system oflatent mycobacte-
rial infection. Latency is induced in a pure culture of Myco-
bacterium by exposing it to multiple stress conditions, includ-
ing a low nutrient culture medium without glycerol, a low pH, 
a relatively high level of carbon dioxide and a relatively low 
gas phase oxygen level. An in vitro model of mycobacterial 
infection employs macrophages induced from THPl cells 
which are then infected with Mycobacterium. The infected 
macrophages are grown under hypoxic conditions to induce 
latency in the mycobacteria. The in vitro model ofinfection is 
useful in evaluating compounds for activity against latent 
mycobacteria. 
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IN VITRO MODEL OF LATENT 
MYCOBACTERIAL INFECTION 
RELATED APPLICATION 
This application is a division of U.S. application Ser. No. 
12/107,146 which was filed on Apr. 22, 2008, and which 
claimed priority from U.S. provisional application Ser. No. 
60/914,838, filed on Apr. 30, 2007. 
FIELD OF THE INVENTION 
The present invention relates to the field of infectious dis-
eases and, more particularly, to a pure culture of Mycobacte-
rium which exhibits latency, including resistance to rifampi-
cin and storage of increased lipids, and to a method for 
generating such a culture. 
BACKGROUND OF THE INVENTION 
Tuberculosis (TB) remains the leading cause of prevent-
able deaths in the world with 100 million new infections and 
two million deaths each year. TB is caused by Mycobacterium 
tuberculosis (hereinafter also referred to by the abbreviation 
"Mtb"), an acid-fast bacillus that is transmitted primarily via 
the respiratory route. The aerosol containing the pathogen is 
released from people with active TB when they cough or 
sneeze. When a person breathes in the pathogen it enters the 
alveolar macrophages via a variety of receptors. Mtb multi-
plies within the vacuoles in the macrophage, avoids fusion 
with the acidic lysosomes and eludes the host defenses. As the 
host defense system senses the multiplying pathogen and 
mounts its immune defense, the pathogen goes into a non-
replicating, drug-resistant, latent state. The protective 
response by the immune system at the site of infection results 
2 
phenotypic resistance in dormant bacteria. Mtb displays dor-
mancy-related phenotypic resistance which is demonstrated 
by the Cornell mouse model. Traditionally, the phenotypic 
resistance is exemplified by resistance to the antibiotic 
Rifampicin (Rif) and is regarded as one of the hallmarks of 
latent TB. The mechanism of phenotypic resistance in dor-
mant Mtb is not clearly understood. 
Development of drugs that can effectively kill dormant 
Mtb is of vital importance for the eradication of TB. If such 
10 
drugs would prevent the pathogen from surviving in a drug-
resistant state, a combination of such drugs with currently 
used antibiotics could drastically shorten the period of treat-
ment for complete cure and lead to global eradication of TB. 
For this purpose, we need to identify processes that are nec-
essary for the pathogen to go into dormancy, survive under the 
15 nonreplicating drug-resistant state, and get reactivated when 
the immune system of the host is weakened. Such steps, 
essential for the latent pathogen, could offer ideal targets for 
novel antilatency drugs that can eliminate the dormant patho-
gen. To achieve these objectives we explored the biochemical 
20 processes that the pathogen uses to survive for such long 
periods under a latent state. It has been known for many 
decades that Mtb in the host uses fatty acids as the major 
source of energy. It is well known that glyoxylate cycle is used 
by organisms that live on fatty acids. In recent years the 
25 important role of isocitrate lyase, a key enzyme uniquely used 
in the glyoxylate cycle, was shown to be required for the 
persistence ofMtb in the host demonstrating the central role 
played by fatty acid catabolism in persistence. However, the 
source of fatty acids used by the pathogen remains unclear. 
30 We postulated that the pathogen probably stores energy as 
triacylglycerol (TG) as it goes into dormancy and uses this 
stored energy to survive the long dormant period at very low 
metabolic rates as many living organisms such as hibernating 
animals, seeds and spores do for similar purposes. We began 
35 to identify the likely gene products that the pathogen uses to 
store TG and to release the fatty acids for catabolism. We also 
initiated the development of an in vitro dormancy model to 
test the hypothesis that lipid storage and mobilization are of 
importance for latency, a model that can be adapted for 
in the formation of a granuloma that contains the infection 
and prevents its spread. Live bacilli have reportedly been 
isolated from granulomas or tubercles in the lungs of persons 
with clinically inactive tuberculosis, regarded as the latent 
form of TB, indicating that the organism can persist in granu-
lomatous lesions for decades. It is estimated that one-third of 
the world population has latent TB. These individuals are 
asymptomatic latent carriers who exhibit no signs of disease. 
Their risk for reactivation is estimated to be 2-23% over their 
life time. One study concluded that a 25 year old with latent 45 
TB has a 7 .3% life time risk of reactivation. The risk increases 
40 screening antilatency drug candidates. 
TG is an important storage form of lipid that accumulates 
in species belonging to the actinomycetes family, particularly 
Mtb. Intracellular TG inclusion bodies were detected in 
mycobacteria isolated from organ lesions and Mycobacte-
rium bovis BCG was reported to preferentially use TG within 
macrophages indicating that TG is probably used as an energy 
source by Mtb during the course of the disease. We have 
shown that TG accumulates when Mtb is subjected to hypoxia 
or nitric oxide treatment that led to a dormancy-like state in 
dramatically for persons coinfected with HIV, more like 10% 
per year. Thus, the advent of AIDS greatly amplified the TB 
threat to human health. The deadly partnership between TB 
and AIDS, especially with multi- and extremely drug-resis-
tant TB, is contributing to a dramatic rise in TB cases world-
wide leading to a grave situation. The emergence and spread 
50 culture. We identified fifteen members of a novel class of 
of multi-drug resistant and extremely drug-resistant TB is 
widely recognized as a major threat to public health. 
The ability of the pathogen to go into the drug-resistant 55 
latent state is a major road block to the eradication ofTB. It is 
known that latent Mtb persists in a non-replicating state. 
Antibiotics used to treat bacterial infection are usually active 
against growing bacteria but not against the dormant patho-
gen. Correlation between antibiotic activity and bacterial 60 
growth state in streptomycin-dependent Mtb was shown 
almost 30 years ago. The antibiotic-resistance of non-grow-
ing bacteria is due to changes in bacterial metabolism or 
physiological state and is described as phenotypic resistance. 
The phenotypic resistance has been classified into three types 65 
based on the physiological state of bacteria as stationary 
phenotypic resistance, persister phenotypic resistance and 
diacylglycerol acyltransferase genes which we designated as 
tgs (triacylglycerol synthase). Several of the tgs genes were 
significantly upregulated under hypoxic conditions and under 
nitric oxide treatment, particularly those that show the highest 
TG synthase activity when expressed in E. coli. We identified 
Rv3130c as the prime gene in the biosynthesis ofTG in the 
bacterium under in vitro dormancy-like conditions. Our 
hypothesis was strongly supported by a important recent 
report on the W /Beijing lineage ofMtb strains which has been 
associated with the increasing incidence of multi-drug resis-
tant (MDR) TB epidemic inAsia. The W/Beijing strains were 
shown to overproduce TG and the R v3130c gene was consti-
tutively upregulated along with the dormancy regulator pro-
tein DosR. The authors suggested that constitutive accumu-
lation ofTG by this strain may confer an adaptive advantage 
for growth inmicroaerophilic or anaerobic environments and 
thus be related to the epidemiological spread of this strain. 
US 8,211,446 B2 
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Our hypothesis concerning the importance of Rv3130c is 
strongly supported by the remarkable finding by our collabo-
rators. A recently developed two step multiplex and real time 
PCR method was adapted for reliable quantitative gene pro-
filing of the small amount oflatent Mtb expected to be found 
4 
The present invention also includes a pure culture, and even 
a single isolated cell of resistant Mycobacterium generated 
according to the method disclosed. 
The invention includes an in vitro model oflatent tubercu-
losis, the model comprising an isolated culture of THPl 
derived macrophages containing ingested Mycobacterium 
tuberculosis bacteria and incubated under hypoxic conditions 
for a time sufficient for the bacteria to accumulate increased 
lipids therein. More broadly, the invention also provides an in 
vitro model oflatent mycobacterial infection, the model com-
prising an isolated culture of THPl derived macrophages 
containing ingested Mycobacterium spp. cells and incubated 
under hypoxic conditions for a time sufficient for the bacteria 
in infected animal and human host lung tissues. Remarkably, 
tgsl (Rv3130c) was by far the most upregulated gene in the 
pathogen within the host, while dosR and aceAa that are 
well-known to be involved in dormancy, were much less 
induced. Many organisms use waxy esters (WE) as the major 10 
form of energy storage. Mtb also stores WE but the genes 
involved in the synthesis of WE and the growth conditions 
that cause its accumulation have not been identified. The 
basic mechanisms used for biosynthesis of WE were first 
elucidated in our laboratory several decades ago and the enzy-
matic strategy described more recently. We have recently 
shown that R v33 91 and R v 1543 encode acy 1-CoA reductases 
involved in WE synthesis in Mtb. Rv3391 has been reported 
15 to accumulate increased lipids therein. More broadly still, the 
invention teaches an in vitro model of mycobacterial infec-
tion, the model comprising an isolated culture of THPl 
derived macrophages containing ingested Mycobacterium 
to be upregulated under nutrient stress conditions. We found 20 
that WE accumulates under stress conditions that lead to a 
spp. cells. 
With regard to the various models disclosed in the inven-
tion, the teachings also comprise a method of making a model 
oflatent tuberculosis, the method including inducing cultured 
THPl cells to differentiate into macrophages; infecting the 
macrophages with Mycobacterium tuberculosis bacteria; and 
dormancy-like state and the accumulated WE is utilized upon 
starvation. This utilization was reduced in lip Y mutant, indi-
cating the involvement oflipY in WE hydrolysis. Thus, Mtb 
can produce and use both major energy storage forms. TG and 
WE, and both forms are likely to be used for successfully 
going through dormancy. WE may also be a component of the 
cell wall lipids that control permeability. 
25 incubating the infected macrophages under hypoxia, particu-
larly wherein incubating is for a time sufficient for the bacte-
ria to accumulate increased lipids therein, a hallmark of 
latency. This method is, in general, also be applicable to other 
SUMMARY OF THE INVENTION 30 
With the foregoing in mind, the present invention advan-
tageously provides a method ofinducing latency inMycobac-
terium, the method comprising growing a pure culture of 
35 Mycobacterium exposed to multiple stress conditions, the 
stress conditions including at least a low nutrient culture 
medium without glycerol, a low pH, a relatively high level of 
carbon dioxide and a relatively low gas phase oxygen level. 
A latent culture of Mycobacterium growing in vitro is 40 
particularly useful in evaluating the effectiveness of antimi-
crobial compounds against this form of the organism, which 
is prevalent throughout the world in infected but asymptom-
atic persons. Before the present invention, it was difficult to 
test drug effectiveness against latent Mtb due to the lack of an 45 
easily reproducible model system. Accordingly, the present 
invention discloses an in vitro model oflatent mycobacterial 
infection which is useful in testing antimicrobials for activity 
against the infection in its latent stage. 
The method of the invention includes growing the Mtb in a 50 
low nutrient medium comprising approximately 10% Dubas 
medium, preferably at a pH of approximately 5 and in an 
atmosphere relatively high in level of carbon dioxide, at 
approximately 10%. Additionally, the atmosphere includes a 
relatively low oxygen level of approximately 5%. Preferably, 55 
in the method, the Mycobacterium is a strain of Mycobacte-
rium tuberculosis. 
Another embodiment of the present invention includes a 
method of inducing a pure culture of Mycobacterium to 60 
become rifampicin resistant and to store an increased lipid 
content, two hallmarks of latency, the method comprising 
growing the culture simultaneously exposed to multiple 
stress conditions, the stress conditions including at least a low 
nutrient culture medium without glycerol, a low pH, a rela- 65 
tively high level of carbon dioxide and a relatively low gas 
phase oxygen level. 
Mycobacterium species as well. 
The various in vitro models of latent tuberculosis and 
mycobacterial infection herein disclosed are useful in evalu-
ating compounds for effectiveness against these bacterial 
pathogens. 
BRIEF DESCRIPTION OF THE DRAWINGS 
Some of the features, advantages, and benefits of the 
present invention having been stated, others will become 
apparent as the description proceeds when taken in conjunc-
tion with the accompanying drawings, presented for solely 
for exemplary purposes and not with intent to limit the inven-
tion thereto, and in which: 
FIG. 1 is a demonstration of the accumulation of storage 
lipids in Mtb cells treated for the indicated periods under the 
multiple stress conditions, according to an embodiment of the 
present invention; TLC was performed as described; the 
plates were charred and quantitation was done by densitom-
etry; 
FIG. 2 shows increasing lipid storage bodies in Mtb cells 
with increasing periods of multiple stress; non-acid fast stain-
ing cells (green) and lipid storage body staining (red) 
increased with time under multiple stresses; cells were 
stained with Auramine-0 and Nile Red and examined by 
confocal laser scanning microscopy (Leica TCS SP5) with 
Z-stacking to get the depth of the scan field; scanned samples 
were analyzed by LAS AF software for image projection; 
FIG. 3 shows an increase in the percentage oflipid-stained 
cells and decrease in percentage of acidfast stained cells in 
Mtb culture when subjected to multiple stresses in vitro; 
FIG. 4 depicts TG accumulation by tgsl (Rv3130c) and 
restoration of TG accumulation by complementation under 
18 days of multiple stress; equal amounts of lipid were sub-
jected to TLC as in FIG. 1; C-lltgsl, is a complemented 
mutant; 
FIG. 5 shows real-time PCR measurements of transcript 
levels oftgs and stress responsive genes in Mtb H37Rv under 
in vitro multiple stress for 9 days; comparative Cr method 
US 8,211,446 B2 
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(llllCr) was used to quantify and values obtained with start-
ing aerated cells were used to calculate the fold induction; 
6 
infected macrophages (lane 1) and from Mtb recovered from 
infected macrophages (lane 2); the solvent system is hexane: 
diethyl ether: acetic acid, 94:4:2, v/v/v, (developed twice); 
FIG. 17 shows TDM infected with Mtb and incubated 
FIG. 6 shows expression profiles of genes encoding pro-
teins involved in the glyoxylate cycle during the multiple 
stress treatment; 5 under hypoxia appear to fuse together; TDM infected with 
Mtb at an MOI of0.1 and incubated for 7 days under 1 % 0 2 
were stained with carbolfuschin followed by hematoxylin 
and eosin (A) or carbolfuschin followed by methylene blue 
FIG. 7 depicts a decrease in buoyant density of Mtb cells 
subjected to multiple stresses; Mtb cells subjected to the 
multiple stresses were placed on the preformed gradient and 
centrifuged at 400 g for 20 min; the center tube is a 3 day cell 
sample mixed with density marker beads; Percoll® gradients 10 
were self-formed by centrifugation from a starting solution 
with a density of 1.0925 gm/ml; the densities of selected bead 
layers (p, in gm/ml) are given on the right and the positions of 
one ml fractions collected for analyses are at the left; numbers 
below the tubes indicate the number of days under multiple 15 
stress; 
FIG. 8 is a bar graph showing that Alamar Blue assay 
reveals development of Rif resistance by multiple-stressed 
Mtb cultures; Mtb cultures subjected to multiple stresses 
were assayed by the specially adapted Alamar Blue method 20 
described in text for resistance to Rif and INH; fluorescence 
readings above 0 h controls are depicted; 
FIG. 9 shows real time PCR measurement of transcripts 
levels of a subset of selected dormancy metabolism and stress 
responsive genes in Mtb H37Rv under in vitro multiple 25 
stresses for 9 and 18 days; a relative quantitation method 
(ddCt) was used with the 7500 Fast real time system; samples 
of starter cultures were used as calibrator to calculate the fold 
induction; 
(B); arrows show Mtb; and 
FIG. 18 shows Mtb inside TDM that accumulate neutral 
lipids lose acid-fastness; intact TDM harboring Mtb were 
fixed with 4% paraformaldehyde overnight and stained with 
the fluorescent mycolic acid staining dye Auramine-0 (A) 
followed by the neutral lipid stain Nile Red. 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENT 
The present invention will now be described more fully 
hereinafter with reference to the accompanying drawings, in 
which preferred embodiments of the invention are shown. 
Unless otherwise defined, all technical and scientific terms 
used herein have the same meaning as commonly understood 
by one of ordinary skill in the art to which this invention 
pertains. Although methods and materials similar or equiva-
lent to those described herein can be used in the practice or 
testing of the present invention, suitable methods and mate-
rials are described below. Any publications, patent applica-
tions, patents, or other references mentioned herein are incor-
FIG. 10 are photomicrographs where Oil Red-0 staining 
reveals lipid droplet accumulation in TDM incubated for 
3-days in 1% 0 2 , 5% C02 (a) compared to 0-day control (b); 
FIG. 11 indicates the increase in lipid bodies in TDM 
infected with Mtb and subjected to hypoxia for 0 and 3-days; 
FIG. 12 shows Mtb within TDM stained withAuramine-0 
and Nile Red showing spherical fluorescent lipid bodies and 
lack of acid fast staining; 
30 porated by reference in their entirety. In case of conflict, the 
present specification, including any definitions, will control. 
In addition, the materials, methods and examples given are 
illustrative in nature only and not intended to be limiting. 
Accordingly, this invention may be embodied in many differ-
35 ent forms and should not be construed as limited to the illus-
FIG. 13 shows that TG accumulated by TDM under 
hypoxia is utilized by Mtb; in A, lipids from uninfected (U) 
and infected (I) TDM, incubated in 20% 0 2 or 1 % 0 2 for 7 40 
days after infection, were resolved on TLC and visualized 
under UV light after spraying with 2',7'-dichlorofluorescein; 
trated embodiments set forth herein. Rather, these illustrated 
embodiments are provided so that this disclosure will be 
thorough and complete, and will fully convey the scope of the 
invention to those skilled in the art. Other features and advan-
tages of the invention will be apparent from the following 
detailed description, and from the claims. 
With the foregoing in mind, an in vitro dormancy model 
that can be adapted to drug screening would help to discover 
antilatency drug candidates, in vitro models suitable for such 
in B, lipids ofMtb recovered from TDM incubated in 20% 0 2 
(i) or 1 % 0 2 (ii); solvent was hexane-ether-formic acid (90: 
10:1, v/v/v) TG, triacylglycerol, FA, fatty acids; 45 screening are urgently needed. A number of different stresses 
have been applied to Mtb in vitro in an attempt to generate a 
dormant state and gene expression changes have been inves-
tigated. Most of these models involve single stress factors 
FIG. 14 depicts the fatty acid composition ofTG from Mtb 
recovered after TDM infection; after infection with Mtb, 
TDM were incubated under 1 % 0 2 for 7 days; TG from Mtb 
isolated from TDM was purified by preparative TLC. Fatty 
acid methyl esters were prepared from Mtb TG and analyzed 50 
using a Varian CP-TAP CB colunm attached to a Varian 
CP-3900 gas chromatograph under a temperature control pro-
gram; 
such as oxygen depletion, nutrient deprivation, NO treatment 
and acidic conditions. The gene expression changes during 
combined nutrient deprivation and 10% and 0.2% oxygen 
stress on stationary phase cultures were investigated. Some of 
these stress conditions such as prolonged nutrient starvation 
caused Mtb to become highly Rif-resistant but accumulation FIG. 15 depicts transcriptional profiling of genes in Mtb 
H37Rv from infected TDM under hypoxia; 
FIG. 16 shows that Mtb inside [14C]acetate-labeled lipid-
loaded macrophages mobilizes host lipids and accumulates 
TG enriched in saturated fatty acids; in A, AgN03 -impreg-
nated silica-TLC purified from [14C]acetate-labeled lipids of 
infected macrophages (lane 1) and from Mtb recovered from 
such macrophages (lane 2); solvent system is 1 % methanol in 
chloroform; in B, is shown reversed-phase TLC analysis of 
fatty acids methyl esters of TG from infected macrophages 
(lane 1) and from Mtb recovered from infected macrophages 
(lane 2); the solvent system is acetonitrile:methanol:water: 
acetic acid (30:70:5:1, by volume); in C. AgN03 -impreg-
nated silica-TLC of fatty acids methyl esters of TG from 
55 of storage lipids was not tested. On the other hand hypoxic 
conditions we used that caused TG accumulation did not 
develop resistance to 5 µg/ml Rif (unpublished). The non-
replicating persistence- I (NRP-1) condition was reported to 
cause resistance to a lower concentration ofRif (1 µg/ml) but 
60 lipid accumulation was not tested. We suggest that both Rif-
resistance and lipid storage are hallmarks of dormancy. Since 
individual stress conditions do not allow the pathogen to fully 
meet these criteria, we attempted to mimic the in vivo condi-
tions by applying multiple stresses thought to be encountered 
65 in vivo by Mtb and tested whether the pathogen would accu-
mulate storage lipids and develop Rif-resistance. Bacilli 
within granulomas encounter low oxygen (5%) but not 
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TABLE 1 
Development ofRif-resistance in wild type H37Rv but not in Rv3130c 
mutant upon application of multiple stress: complementation restores 
Rif-resistance. Aliquots were either untreated or treated with 
Rif (5 µg/ml) or !NH (0.8 µg/ml). 
Mtb Resistance to Antibiotics(%) 
strains Days !NH (0.8 µg/ml) Rif (5.0 µg/ml) 
hypoxia, high C02 (10%) concentrations, low nutrient levels 
and acidic pH. Based on these reports, we used 5% 0 2 , 10% 
C02 , pH 5.0 and 10% Dubas medium in a multiple stress in 
vitro model. Our preliminary results show that the combina-
tion of the four stress factors leads to accumulation of storage 
lipids (TG and WE), development ofRif-resistance and gene 
expression changes thought to be associated with dormancy. 
Some of the gene expression changes are similar to those 
found in the pathogen from infected lungs of hosts, including 
primates and a human TB patient. 10 
WT- 0 day 
H37Rv 9 day 
0.034 (±0.02) 0.037 (±0.027) 
34.7 (±12) 4.7 (±1.9) 
Both Rif-resistance and storage lipid accumulation are 
associated with dormancy. However, the commonly used in 
vitro hypoxia model, does not show both of these character-
LI.-
Rv3130c 
(LI.-
18 day 
0 day 
9 day 
18 day 
84.4 (±17.5) 12.5 (±3.4) 
0.011 (±0.01) 0.025 (±0.019) 
21.1 (±7.8) 1.16 (±0.87) 
31.2 (±13.1) 1.89 (±0.9) 
15 istics. Therefore we developed a novel multiple stress model 
tgsl) 
Comple- 0 day 0.041 (±0.02) 0.029 (±0.01) 
that applies four different stresses that the pathogen is thought 
to encounter in the host. We grew Mtb cultures in low pH (pH 
5.0), low nutrient (10%) Dubas medium without glycerol, 
with high (10%) C02 and low (5%) oxygen gas phase. 
Mtb cultures in 10%Dubos (Difco)mediumatpH 5.0atan 
OD 600 of 0.2 were maintained under 5% 0 2 +10% C02 + 
20 
LI.-
Rv3130c 
ND, Not determined; 
d, day. 
9 day 37.9 (±13.5) 5.2 (±2.1) 
18 day 91 (±19) 11 (±4.5) 
85% N2 by replacing the air phase every other day; oxygen 25 
levels did not change significantly during the two day period. 
Gene expression changes directly relevant to storage lipid 
accumulation were examined by real-time PCR. Among all 
the tgs genes, induction of tgsl (Rv3130c) was by far the 
highest at 9 days under the multiple stress condition, followed 
by Rv3371 and Rv3088 (FIG. 5). Microarray analysis also 
indicated upregulation ofRv3371 under multiple stress con-
After monitoring the progressive changes that happened to 
the pathogen, we chose to harvest cells at 3, 9 and 18 days 
under such conditions for more detailed studies. These stud- 30 
dition (data not shown). Upregulation of Rv3088 probably 
resulted from the low pH as it has been previously reported to 
be induced under acidic stress. Up-regulation of Rv3371 is 
noteworthy as it was also shown to be up-regulated in human ies included examination of storage lipids, antibiotic (Rif and 
INH)-resistance, gene expression changes directly relevant to 
storage lipid synthesis by quantitative real time PCR ( qPCR), 
and gene expression profiles by microarray analyses. TLC 35 
showed that WE and TG accumulated under the multiple 
lung granuloma by microarray analysis. The degree of induc-
tion oftgsl (Rv3130c) was comparable to that of icl and acr 
(hspX), genes previously reported to be induced during per-
sistence. Our preliminary experimental results raise the pos-
sibility that lipid accumulation under different stress condi-
stress conditions reaching near maximal levels by 9 days FIG. 
1. 
The major wax ester was oleyl oleate and the major fatty 
acids in the TG were C16 and C18 with less C26 (data not 
shown). Under these conditions more WE accumulated than 
TG in absolute amounts. Control samples at pH 7 .0 or pH 5 .0 
without additional stress showed no increase in storage lipids. 
Nile red staining revealed storage lipid accumulation under 
the multiple stress conditions. It is well known that Mtb 
cultures contain a heterogeneous population of cells under 
different physiological states. As the culture was subjected to 
multiple stress factors we observed decrease in acid fast stain-
ing cells with increasing lipid body staining cells from a 
barely detectable level to a significant percentage of the total 
cells by 18 days (FIGS. 2, 3). 
tions might use different sets oftgs genes. 
The TIGR Pathogen Functional Genomics Resource Cen-
ter provided the Mtb genome microarray for this study. Under 
40 our multiple stress condition, genes that encode enzymes 
involved in glyoxylate cycle such as isocitrate lyase (aceA) 
and citrate synthase (gltAl) showed significant increase in 
expression for all time points examined (FIG. 6). From these 
data we infer that the metabolic regulation of cells adapting to 
45 the multiple stresses was similar to that observed in persistent 
bacilli adapting to the phagosomal environment of a mac-
rophage. Under multiple stresses, Mtb showed shutdown of 
both ATP/NAD energy regeneration systems. While gene 
expression for anaerobic respiration was continuously 
50 increased at the later time points, the aerobic respiration was 
significantly repressed at all the time points. All the subunits 
encoding NADH dehydrogenase and the ubiquinol-cyto-
chrome C complex were repressed more than 2-fold. In addi-
Drug resistance was tested by treatment with 5 µg/ml Rif 
for 5 days followed by serial dilution and plating. By 9 days 55 
about 10% of the cells were found to be Rif resistant whereas 
tion, the expression of the genes encoding ATP synthase 
subunits was repressed. Slowdown of the transcription/trans-
lation apparatus was evident during the multiple stresses. 
the starting culture contained about 0.03% Rif-resistant cells. 
Rif-resistance increased up to 18 days, sometimes reaching 
up to 25% at 5 µg/ml Rif. The tgsl (Rv3130c) disruption 
resulted in the loss ofRif-resistance which was restored in the 
complemented mutant (Table 1 ). Hypoxic conditions, that 
were previously found to cause accumulation of storage lip-
ids, did not cause the cells to develop detectable Rif-resis-
tance at 5 µg/ml. The tgsl (Rv3130c) disruption resulted in 
loss of TG accumulation under multiple stress. However the 
complemented mutant showed a level of TG accumulation 
comparable to the wild type (FIG. 4). 
Many genes related to transcription and translation apparatus 
were all consistently repressed. Genes involved in modifica-
tion of chromosome and cell division were repressed by the 
60 multiple stresses. The expression level of the gene cluster, 
mas, fad28, mmpL7, and ppsA-E, associated with phthioc-
erol dimycocerosate (PDIM) synthesis and transport, that 
was repressed at the beginning of the multiple stress treat-
ment, gradually increased more than two-fold and remained 
65 high throughout the period of in vitro multiple stress. Further, 
the mas-like gene pks2, which is responsible for encoding a 
hepta/octa-methyl branched fatty acid synthase, was highly 
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expressed. These changes are consistent with the report that 
dormant cells have thickened walls. We also found significant 
induction of the genes classified as the stress response genes 
( eg. hspX) that has been suggested to play a role in maintain-
ing long term survival within the host. The gene array analysis 5 
results were verified by qPCR analysis of selected test genes. 
Repressed and induced gene transcript level changes indi-
cated by microarray analysis were found to be consistent with 
the changes indicated by the qPCR method (data not shown). 
We investigated whether the lipid accumulation that occurs 10 
as a result of multiple stresses might be reflected in changes in 
buoyant density. We fractionated the culture on a Percoll® 
gradient in 10 ml Seton Easy-Seal polyallomer centrifuge 
tubes with Seton Noryl crown assembly. This procedure 
resolved cells based on buoyant density (FIG. 7). The banding 15 
pattern changed as the cultures were subjected to multiple 
stresses for increasing duration. These changes are consistent 
with the conclusion that application of multiple stresses 
caused progressive changes in lipid accumulation resulting in 
increasing percentages of cells in the lighter fractions. 20 
Auramine-0/Nile Red staining of the different fractions 
showed that with increasing periods under the multiple 
stresses, increasing percentage of cells became lipid-loaded 
and lost acid-fast staining (presumably dormant cells). Stain-
ing of Percoll® fractions from 18 day stressed cultures 25 
showed that the lighter fractions were more enriched in, lipid 
loaded cells that lost acid-fastness. After this long stress 
period most cells were in the lighter fractions (FIG. 7). Upon 
Percoll® density gradient fractionation of the 18-day mul-
tiple-stressed culture, the great majority of the cells were 30 
distributed in the lighter fractions. When Rif-resistance was 
assessed by the Alamar Blue dye method the lighter fractions 
showed a higher percentage of Rif-resistant cells (data not 
shown). The small number of heavier cells present in this 
culture showed Rif-susceptibility comparable to that of the 35 
starting culture. 
Recent meta-analysis ofMtb microarray data from many in 
vitro and in vivo conditions that are thought to induce dor-
mancy (Murphy and Brown, BMC Infect. Dis. I, 84-100, 
2007) indicated that a set of genes possibly involved in lipid 40 
storage and utilization are highly upregulated. We have deter-
mined the transcriptional profile of the genes, selected on the 
basis of the meta-analysis by real-time PCR using 7500 Fast 
system (Applied Biosystem). Detection of transcriptional 
upregulation of the known dormancy-responsive genes such 45 
as hspx, icl and dosR (FIG. 1) is consistent with our conclu-
sion that the multiple stress conditions induce dormancy. 
Seven of the 10 genes in the first priority group, such as 
Rv3130c along with a few othertgs genes (Rv3371, Rvl 760), 
a few genes encoding potential hydrolases (lipX lipY, cut3), 50 
and fatty acy 1-CoA reductase gene (R v33 91) showed upregu-
lation. Three of the 21 genes in the next priority group showed 
upregulation under the multiple stress condition. One of them 
showed surprisingly high induction. The other two upregu-
lated genes in this group were cut2 and lipZ. Only one gene 55 
(Rv2285, a tgs) in the third priority group showed upregula-
tion. Among the tgs products that showed the highest enzy-
matic activity (when expressed in E. coli) only this tgs 
showed a preference for oleoyl-CoA. We already have mutant 
for this gene and this mutant showed the second most 60 
impaired ability to accumulate TG under hypoxia as indicated 
in the preliminary results presented in the application. 
It is noteworthy that 7 of the 10 genes in the first priority 
group and 3 out of 21 genes from the second priority group 
and only one out of 17 in the third priority group showed 65 
upregulation. Since the prioritization is based on meta-analy-
sis of the degree of their upregulation under a variety of 
10 
conditions thought to induce dormancy, our results suggest 
that the multiple stress model reflects real dormancy and adds 
validity to our approach. 
The tuberculous granuloma, which is thought to be a 
hypoxic environment, consists of a core ofMtb-infectedmac-
rophages surrounded by lipid-loaded macrophages, mono-
nuclear phagocytes and lymphocytes enclosed by a fibrous 
cuff. The differentiation of macrophages into lipid-loaded 
macrophages in tuberculous granulomas is a well-docu-
mented observation and the secretion of cytokines by the 
infected lipid-loaded macrophages probably helps to main-
tain the granuloma. Histological studies revealed the pres-
ence of lipid-loaded macrophages in the granulomas of 
immunocompetent and HIV-1 infected patients with TB. 
Lipid-loaded macrophages contain abundant cytosolic stores 
of TG and cholesterol esters. A recent study showed that 
exposure of human macrophages to hypoxia (1 % 02) con-
verted them into lipid-loaded cells and M. bovis BCG infec-
tion induced the conversion of macrophages into lipid-loaded 
cells but the nonpathogenic Myca bacterium smegmatis failed 
to induce lipid body formation. Thus lipid bodies within 
Mtb-infected macrophages may have important roles in 
pathogenesis and possibly in latency. Human THP-1 mono-
cytic cell line-derived macrophages (TDM) are known to be 
converted into lipid-loaded macrophages. Therefore they can 
serve as a more convenient experimental model for studies on 
Mtb mutants, because their use can avoid the variability in 
responses encountered in the use of human peripheral blood 
monocyte-derived macrophages and provide a readily avail-
able uniformly reproducible cell model suitable for high 
throughput screening of drug candidates. Lipid bodies have 
been found in Mtb obtained from patients with active disease. 
However, the origin of these lipids remains unknown. The 
pathogen inside the lipid-loaded macrophages might utilize 
fatty acids derived from the lipid bodies in the host cells to 
store lipids within Mtb for later use. Such a possibility was 
raised by the recent finding that adipocytes might be a home 
for dormant Mtb in humans. In fact, Mtb inside adipocytes 
were found to accumulate lipid bodies while becoming dor-
mant, as indicated by their resistance to killing by drugs. The 
lipid bodies found in the pathogen from patients probably 
originate from the lipid bodies in the macrophages. Our 
results indicate that Mtb within lipid-loaded macrophages 
can use the host's TG to accumulate TG within the pathogen 
and this Mtb becomes Rif resistant meeting our criteria for 
dormancy. 
A New Lipid-loaded Macrophage Model of Dormancy 
Herein we disclose a newly developed THP-1 derived mac-
rophage (TDM) system for infection with Mtb. THP-1 cells, 
differentiated into macrophages by treatment with 100 nM 
PMA for 3 days, were incubated for 3 days in 1 % 0 2 and 5% 
C02 . Oil Red-0 staining revealed lipid droplet accumulation 
in such macrophages (FIG. 2). When the TDM were infected 
with Mtb at a multiplicity of infection (MOI) of 1.0 for 4 hr 
and incubated in 1 % 0 215% C02 for 3 days, lipid bodies 
accumulated in the host cells (FIG. 3). Mtb cells within the 
macrophages showed Nile Red stained lipid bodies (FIG. 4). 
Most Mtb cells showed loss of acid fast staining and thus 
stained only red; a few showed some acid fast and lipid 
staining (yellow). 
We modified our experimental protocol to allow for longer 
incubation of infected macrophages. We infected TDM with 
Mtb at an MOI of0.1 (1 bacillus per 10 macrophages) and 
extended the incubation of the infected TDM to 7 days under 
hypoxia. After 7 days, infected TDM were lysed and the cell 
debris was removed by centrifugation at 300 g for 10 min. The 
Mtb cells were pelleted by centrifugation at 3000 g for 10 min 
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and washed. Lipids from the host-lipid bodies were extracted 
from the supernatant and the lipids from the pelleted To 
analyze fatty acid composition, host or Mtb TG was purified 
by preparative TLC and the methyl esters generated by BF3/ 
methanol transesterification, were analyzed by capillary GC. 5 
The amount of fatty acids from the TG isolated from Mtb, 
recovered for TDM, is more than enough for such GC analy-
sis (FIG. 6) pathogens were extracted. TLC analysis of the 
lipids revealed that TG in the host cells was markedly 
increased by incubation under hypoxia for 7 days and the 10 
levels of TG were lower in infected TDM under hypoxia 
(FIG. SA). Lipids extracted from Mtb recovered from 
infected TDM were also analyzed by TLC. We detected 
increased TG level in Mtb cells recovered from TDM incu- 15 
bated under hypoxic conditions (FIG. 5). 
The fatty acid composition of the TG from the pathogen 
was not identical to that of the host TG. Cl 6:0, Cl 8:0 and 
12 
The recovered Mtb cells were diluted and plated on agar 
plates without antibiotic and incubated for 4 weeks after 
which cfus were enumerated. Antibiotic resistance is 
expressed as percentage of control without antibiotic. As 
indicated in Table 2, Mtb recovered from TDM incubated 
under 20% 0 2 showed resistance to both antibiotics. Others 
have found development of Rif resistance in host cells. We 
found that Rif resistance increased significantly in Mtb recov-
ered from TDM incubated under 1 % 0 2 for 7 days compared 
to normoxic conditions. These results indicate support for our 
hypothesis that lipid-loading of macrophages favor the entry 
ofMtb into dormancy. 
Lipid-loaded Macrophage Model 
In making further progress developing the macrophage 
dormancy model, we tested different MOI in the lipid loaded 
macrophage system. We assessed the viability of Mtb-in-
fected lipid-loaded macrophages under hypoxia under differ-
ent MOL At MOI 1.0 or higher the host cell viability was 
seriously compromised. At MOI 0.1, after 7 days under 1 % 
0 2 , 40% of the original TDM population remained intact as 
an adhered monolayer and were loaded with lipid droplets. 
About 94% of these lipid-loaded TDM cells in the adhered 
mono layer were viable. These results support the notion that 
these lipid-loaded TDMs provide a TG-enriched sanctuary 
Cl 8: 1 fatty acids were the dominant components in both the 
pathogen and the host. Longer chain saturated fatty acids 20 
(C24. C26 and C28) that were present in the pathogen TG 
were absent in the host TG. We conclude that the TG that 
accumulated in the pathogen probably consisted of fatty acids 
from the host and some fatty acids generated within the patho-
gen. 25 for Mtb, favoring its entry into dormancy. 
Gene expression changes occurring in the pathogen within 
TDM were examined using a two-step real time PCR method. 
Briefly, total RNA was isolated and purified from a mixture of 
Mtb-infected TDM using Trizol (Invitrogen) and Qiagen 
RN easy colunm purification method. Total RNA was DNase 30 
treated twice, purified through Qiagen mini elute RNeasy 
colunm, purity of RNA was checked at every step. Controls 
without reverse transcription (RT) verified lack of DNA con-
tamination. First-strand cDNA, synthesized with exo-resis-
tant random hexamers and Superscript III reverse tran-
scriptase (Invitrogen) was used for multiplex PCR using 
many Mtb gene specific primer sets. All primers and Taqman 
probes were designed using VisualOMP6 software from 
DNA software, Inc (Ann Arbor. MI). The Taqman probes 
have a fluorescein reporter dye (FAM) at 5'-end and a Black 
Hole Quencher (BHQ) at 3'-end. Each multiplex and real-
time PCR primer was checked for specificity and efficiency. 
Differences in Mtb specific gene transcripts were quantified 
35 
40 
by real-time PCR on generated multiplex-PCR products with 
nested Taqman primers and probes. The overall reliability and 45 
sensitivity of the two-step RT-PCR method to quantify gene 
expression profiling has been discussed in detail elsewhere. 
We have thus far done only a subset of genes thought to be 
relevant to lipid storage and metabolism (FIG. 7); icl was by 
far the most induced gene, consistent with the idea that the 50 
pathogen in TDM grows on fatty acids. It is noteworthy that 
lip Y, that was previously shown by us to be involved in TG 
mobilization, was highly induced and some of the other lip 
genes also showed induction. dosR and tgs genes were also 
induced probably indicating their involvement in the storage 55 
of fatty acids derived from host-lipids as TG resynthesized 
within the pathogen, consistent with our hypothesis. fatp, that 
might be involved in fatty acid transport into the pathogen 
was also induced. Putative fabp genes also showed some 
induction. These results indicate that our hypothesis concern- 60 
ing storage and mobilization of host lipids by the pathogen 
has real validity. 
We analyzed the resistance of Mtb recovered from TDM 
after a 7 day incubation under 20% 0 2 or 1 % 0 2 to Rif and 
INH by cfu determination. TDM were infected with Mtb at an 65 
MOI ofO.l. Mtb cells inside TDM were exposed to antibiotic 
for 2 days prior to lysis ofTDM and recovery of the bacilli. 
TABLE2 
Increase in resistance ofMtb inside lipid-loaded macrophages to Rif 
and !NH. Mtb within TDM incubated for 7 days under 20% 0 2 or 
1 % 0 2 was exposed to antibiotic for 2 days. Mtb cells were then 
recovered by lysis ofTDM and plated on agar plates for cfu 
determination. 
Mtb 
recovered 
from TDM Resistance to Antibiotic 
incubated Rif !NH 
7 days in 1 µg/ml 5 µg/ml 0.1 µg/ml 0.8 µg/ml 
20%02 9% 4% 25% 12% 
1%02 68 ± 14% 25 ±2% 100% 68 ± 18% 
We originally suspected that Mtb utilizes the macrophage 
lipid bodies to acquire fatty acids and store them as TG within 
the pathogen to enable it to go through dormancy. To test this 
hypothesis, we labeled TDM lipids by incubating the cells 
with [ 14C]acetic acid or [ 14C]oleic acid, under 1 % 0 2 for 2 
days. These cells were washed three times with sterile phos-
phate-buffered saline (PBS) to remove unincorporated radio-
label. Thin-layer chromatographic (TLC) analysis of the 
labeled lipids extracted from TDM showed that major part 
(about 60%) of the radioactivity in the lipids derived from 
labeled acetate and oleate was in TG that accumulated in 
TDM under 1 % 0 2 . These pre-labeled cells were infected 
with Mtb at an MOI of 0.1 for 4 h under 1 % 0 2 . Following 
infection, extracellular Mtb were removed by thoroughly 
washing the TD M monolayer with sterile PBS. Infected TD M 
were incubated for 5 more days under 1%02 . The host lipids 
and lipids from Mtb recovered from the host cells were 
obtained and the lipids were analyzed by TLC. The fatty acid 
composition of the Mtb and host TGwas analyzed by resolv-
ing the intact TG and fatty acid methy 1 esters derived from TG 
on reversed-phase silica-TLC and argentation-TLC. Analysis 
of intact TG from [1 4C]acetate in TDM was composed of 
saturated and unsaturated fatty acids. However, the TG ofMtb 
was predominantly composed of saturated fatty acids as indi-
cated by greater mobility onAgN03 -impregnated TLC (FIG. 
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SA). Analysis of fatty acid methyl esters prepared from TG 
isolated from TDM and Mtb indicated that the TG of Mtb, 
recovered from TDM labeled with [14C]acetate, was com-
posed primarily of saturated fatty acids, mostly 14C-l 6:0 and 
14 
by Nile Red which stains neutral lipids. Interestingly, as seen 
in FIG. 9, theMtb-infected TDM which were incubated under 
hypoxia for 7 days appeared to be fusing together. It is prob-
a very small quantityof 14C-18:0fatty acids (FIG. 8). See also 5 
Table 3, below. 
able that these TDM are in the process of forming multinucle-
ate giant cells (asterisk in FIG. 9) which are known to be 
present in the hypoxic environment of the granuloma in close 
vicinity to lipid-loaded macrophages. These observations 
support the hypothesis that this lipid-loaded macrophage sys-
tem is a good model for in vivo latency. 
TABLE3 
Accumulation of radio labeled TG by Mtb and mutants in 
lipid-loaded macrophages under hypoxia: 
DPMin TG %ofWT 
14C-Acetate WT 210,000 100% 
L\.Rv3130c 22,600 11% 
14C-Oleate WT 29,000 100% 
L\.Rv3130c 1470 5% 
Mtb recovered from [14C]oleic acid-labeled TDM had TG 
that was distinctly different in fatty acid composition from the 
TG in TDM. While the 14C in TDM TGwas predominantly in 
18:0 (about 81% of total fatty acids), 14C in Mtb TG was 
mainly in unsaturated fatty acids (about 70% of total fatty 
acids). The identity of these fatty acids is to be determined. 
These results clearly indicate that Mtb acquires fatty acids 
from TDM lipid bodies for synthesizing TG as a potential 
energy source. The TG stored within the pathogen probably 
includes the fatty acids from the host lipids and fatty acids 
generated by modification and/or catabolism and resynthesis. 
The biochemical processes involved can be deduced only 
after further characterization of the TG that accumulates in 
the host and in the pathogen. 
We also postulated that the Mtb tgs gene products may be 
pivotally involved in synthesizing TG within the Mtb cell 
from fatty acids acquired from host TG. To test this hypoth-
esis, we infected the pre-labeled TDM with wild-type Mtb 
and tgsl (Rv3130c) deletion mutant (llRv3130c) as described 
in the methods section. About 1 % of the radio label in the TG 
in TDM was found in the TG isolated from Mtb. We quanti-
tated the radioactivity in the TG ofMtb and llRv3130c recov-
eredfrom TDM. The results indicatethatTG accumulation by 
the ll3130c was decreased by 90-95% when compared to the 
wild-type (Table 3). These results additionally suggest that 
Rv3130c plays an essential role in the accumulation ofTG by 
Mtb within lipid-loaded macrophages. 
In order to visualize the Mtb inside lipid-loaded host cells, 
infected TDM after 7 days under hypoxia were fixed with 4% 
paraformaldehyde and stained for Mtb with carbolfuschin 
followed by methylene blue or hematoxylin and eosin to stain 
the host cell. Mtb inside TDM were also stained with the 
mycolic acid-specific fluorescent dye Auramine-0 followed 
10 Individual Mtb cells inside TDM that accumulated neutral 
lipids, as indicated by Nile Red staining, lost acid-fastness as 
shown by weak or total loss of Auramine-0 staining (FIG. 
10). Conversely, Mtb cells which stained strongly with 
Auramine-0 did not accumulate neutral lipids. This accumu-
15 lation of neutral lipids and loss of acid-fastness by a subset of 
Mtb cells within lipid-loaded TDM under hypoxia, correlates 
well with our data in the Preliminary Results, that demon-
strated the development ofRif resistance by about 25% of the 
Mtb population and increase in TG within Mtb from TDM 
20 under the same conditions. Since then, we have reconfirmed 
these results with additional experiments. 
Based on these results, the multiple stress in vitro latency 
model disclosed herein appears to be the best one available for 
screening chemicals to discover drug candidates that can 
25 eliminate latent pathogen. Accordingly, in the drawings and 
specification there have been disclosed typical preferred 
embodiments of the invention and although specific terms 
may have been employed, the terms are used in a descriptive 
sense only and not for purposes of limitation. The invention 
30 has been described in considerable detail with specific refer-
ence to these illustrated embodiments. It will be apparent, 
however, that various modifications and changes can be made 
within the spirit and scope of the invention as described in the 
foregoing specification and as defined in the appended 
35 claims. 
That which is claimed: 
1. A method of inducing a pure culture of Mycobacterium 
to become rifampicin resistant and to store an increased lipid, 
the method comprising growing the culture simultaneously 
40 exposed to multiple stress conditions, the stress conditions 
including at least a low nutrient culture medium without 
glycerol, wherein said low nutrient medium is 10% Dubas 
medium or less, a low pH, wherein said low pH is a pH of 5 or 
less, a relatively high level of carbon dioxide, wherein said 
45 relatively high level of carbon dioxide is 10% or higher, and 
a relatively low gas phase oxygen level, wherein the relatively 
low oxygen level is 5% or lower. 
2. The method of claim 1, wherein the Mycobacterium is a 
strain of Mycobacterium tuberculosis. 
* * * * * 
